METFORMIN HYDROCHLORIDE

METFORMIN HYDROCHLORIDE was reported 59278 times

These side effects are most commonly reported by patients taking METFORMIN HYDROCHLORIDE:

# Side effect Count
0 LACTIC ACIDOSIS 4696
1 DIARRHOEA 4541
2 NAUSEA 3682
3 ACUTE KIDNEY INJURY 3416
4 FATIGUE 3261
5 DRUG INEFFECTIVE 2895
6 VOMITING 2749
7 DYSPNOEA 2734
8 HEADACHE 2425
9 OFF LABEL USE 2297
10 DIZZINESS 2243
11 ASTHENIA 2184
12 PAIN 2163
13 FALL 1988
14 MALAISE 1862
15 BLOOD GLUCOSE INCREASED 1829
16 ARTHRALGIA 1721
17 HYPOGLYCAEMIA 1704
18 COUGH 1696
19 WEIGHT DECREASED 1628
20 PRURITUS 1601
21 DECREASED APPETITE 1591
22 PNEUMONIA 1522
23 TOXICITY TO VARIOUS AGENTS 1515
24 HYPOTENSION 1505
25 METABOLIC ACIDOSIS 1457
26 PAIN IN EXTREMITY 1422
27 RASH 1385
28 PRODUCT DOSE OMISSION ISSUE 1346
29 HYPERTENSION 1288
30 CONDITION AGGRAVATED 1287
31 DEATH 1258
32 ABDOMINAL PAIN 1207
33 PYREXIA 1197
34 CONFUSIONAL STATE 1185
35 ABDOMINAL DISCOMFORT 1149
36 DRUG INTERACTION 1101
37 WEIGHT INCREASED 1018
38 NASOPHARYNGITIS 1016
39 ABDOMINAL PAIN UPPER 1012
40 CONSTIPATION 1002
41 DEPRESSION 998
42 RENAL FAILURE 997
43 PRODUCT USE IN UNAPPROVED INDICATION 984
44 PERIPHERAL SWELLING 977
45 INSOMNIA 971
46 BACK PAIN 967
47 ANXIETY 964
48 EXPOSURE DURING PREGNANCY 963
49 DIABETES MELLITUS 951
50 MUSCLE SPASMS 933
51 DEHYDRATION 925
52 URINARY TRACT INFECTION 919
53 COVID-19 909
54 ANAEMIA 901
55 BLOOD PRESSURE INCREASED 886
56 DRUG HYPERSENSITIVITY 861
57 CHEST PAIN 860
58 OVERDOSE 857
59 HYPERKALAEMIA 838
60 ASTHMA 809
61 GAIT DISTURBANCE 803
62 COMPLETED SUICIDE 796
63 SOMNOLENCE 796
64 MUSCULAR WEAKNESS 793
65 PARAESTHESIA 773
66 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 727
67 MYALGIA 705
68 INJECTION SITE PAIN 695
69 FEELING ABNORMAL 692
70 MEMORY IMPAIRMENT 686
71 GASTROINTESTINAL DISORDER 685
72 HYPOAESTHESIA 672
73 HYPERGLYCAEMIA 663
74 CEREBROVASCULAR ACCIDENT 662
75 DRUG INTOLERANCE 662
76 INTENTIONAL OVERDOSE 657
77 ABDOMINAL DISTENSION 656
78 GASTROOESOPHAGEAL REFLUX DISEASE 656
79 JOINT SWELLING 654
80 MATERNAL EXPOSURE DURING PREGNANCY 654
81 HYPERSENSITIVITY 653
82 ILLNESS 636
83 URTICARIA 632
84 ALOPECIA 624
85 GENERAL PHYSICAL HEALTH DETERIORATION 624
86 SINUSITIS 615
87 DYSPEPSIA 611
88 INFLUENZA 609
89 LOSS OF CONSCIOUSNESS 606
90 PRODUCT USE ISSUE 606
91 RENAL IMPAIRMENT 604
92 WHEEZING 596
93 HYPERHIDROSIS 595
94 ERYTHEMA 593
95 TYPE 2 DIABETES MELLITUS 592
96 SYNCOPE 583
97 MYOCARDIAL INFARCTION 577
98 OEDEMA PERIPHERAL 574
99 RHEUMATOID ARTHRITIS 564
100 DIABETES MELLITUS INADEQUATE CONTROL 561
101 DIABETIC KETOACIDOSIS 559
102 CHEST DISCOMFORT 556
103 TREMOR 543
104 SHOCK 527
105 DRY MOUTH 516
106 CARDIAC ARREST 514
107 GLYCOSYLATED HAEMOGLOBIN INCREASED 509
108 CARDIAC FAILURE 504
109 VISION BLURRED 504
110 ATRIAL FIBRILLATION 501
111 LUNG DISORDER 500
112 INTENTIONAL PRODUCT USE ISSUE 496
113 BLOOD CREATININE INCREASED 494
114 MIGRAINE 494
115 SWELLING 494
116 INCORRECT DOSE ADMINISTERED 493
117 BRONCHITIS 492
118 INFECTION 491
119 DRY SKIN 490
120 RENAL FAILURE ACUTE 490
121 BALANCE DISORDER 487
122 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 478
123 C-REACTIVE PROTEIN INCREASED 472
124 OSTEOARTHRITIS 472
125 PALPITATIONS 471
126 FOETAL EXPOSURE DURING PREGNANCY 470
127 BLOOD CHOLESTEROL INCREASED 467
128 HAEMOGLOBIN DECREASED 467
129 FLUSHING 466
130 MOBILITY DECREASED 466
131 OROPHARYNGEAL PAIN 460
132 SEPSIS 460
133 LOWER RESPIRATORY TRACT INFECTION 454
134 BLISTER 452
135 HEART RATE INCREASED 451
136 MUSCULOSKELETAL STIFFNESS 448
137 PRODUCTIVE COUGH 446
138 EYE PAIN 444
139 NEUROPATHY PERIPHERAL 435
140 SLEEP DISORDER 435
141 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 434
142 EUGLYCAEMIC DIABETIC KETOACIDOSIS 431
143 BLOOD GLUCOSE DECREASED 428
144 CHILLS 421
145 PSORIATIC ARTHROPATHY 418
146 SUICIDE ATTEMPT 409
147 CATARACT 408
148 HEPATIC ENZYME INCREASED 407
149 RHINORRHOEA 404
150 SKIN EXFOLIATION 401
151 CHRONIC KIDNEY DISEASE 398
152 PSORIASIS 398
153 ARTHROPATHY 392
154 UPPER RESPIRATORY TRACT INFECTION 391
155 CONTUSION 390
156 VISUAL IMPAIRMENT 390
157 ARTHRITIS 387
158 HYPONATRAEMIA 382
159 INFUSION RELATED REACTION 380
160 CONTRAINDICATED PRODUCT ADMINISTERED 376
161 OXYGEN SATURATION DECREASED 375
162 NEUTROPENIA 374
163 PULMONARY EMBOLISM 373
164 TACHYCARDIA 373
165 INFLAMMATION 368
166 PANCREATITIS 368
167 ADVERSE DRUG REACTION 363
168 PLATELET COUNT DECREASED 361
169 BLOOD PRESSURE DECREASED 360
170 WOUND 360
171 BRADYCARDIA 359
172 RESPIRATORY FAILURE 358
173 DYSARTHRIA 354
174 HOSPITALISATION 350
175 HYPOKALAEMIA 350
176 SYNOVITIS 349
177 CARDIAC DISORDER 347
178 DYSPNOEA EXERTIONAL 347
179 MULTIPLE ORGAN DYSFUNCTION SYNDROME 346
180 STOMATITIS 345
181 DRUG-INDUCED LIVER INJURY 343
182 MUSCULOSKELETAL PAIN 343
183 DYSPHAGIA 341
184 WHITE BLOOD CELL COUNT DECREASED 341
185 HOT FLUSH 340
186 THROMBOCYTOPENIA 336
187 THROMBOSIS 335
188 HYPOTHYROIDISM 333
189 OEDEMA 333
190 NECK PAIN 332
191 PRODUCT QUALITY ISSUE 330
192 INFLUENZA LIKE ILLNESS 326
193 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 325
194 CARDIAC FAILURE CONGESTIVE 320
195 COMA 320
196 GAIT INABILITY 319
197 TASTE DISORDER 317
198 INJURY 316
199 PANCREATITIS ACUTE 310
200 THERAPEUTIC PRODUCT EFFECT DECREASED 310
201 TREATMENT FAILURE 308
202 STRESS 307
203 OBESITY 303
204 ILL-DEFINED DISORDER 301
205 NEPHROLITHIASIS 301
206 CELLULITIS 298
207 FLATULENCE 298
208 NIGHT SWEATS 292
209 NASAL CONGESTION 288
210 DRUG LEVEL INCREASED 287
211 RHABDOMYOLYSIS 287
212 EPISTAXIS 286
213 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 285
214 BURSITIS 284
215 BLOOD PRESSURE SYSTOLIC INCREASED 282
216 IMPAIRED HEALING 282
217 FIBROMYALGIA 278
218 ADVERSE EVENT 274
219 INTENTIONAL PRODUCT MISUSE 274
220 IRRITABLE BOWEL SYNDROME 272
221 DEPRESSED MOOD 271
222 LETHARGY 270
223 LIVER INJURY 269
224 EPILEPSY 268
225 SEIZURE 267
226 SYSTEMIC LUPUS ERYTHEMATOSUS 266
227 PERICARDITIS 265
228 DISCOMFORT 264
229 GLOSSODYNIA 262
230 DYSGEUSIA 261
231 JOINT RANGE OF MOTION DECREASED 260
232 FEELING HOT 259
233 FOLLICULITIS 259
234 BURNING SENSATION 257
235 POLLAKIURIA 257
236 FLUID RETENTION 256
237 ALANINE AMINOTRANSFERASE INCREASED 255
238 ANAPHYLACTIC REACTION 254
239 THERAPY INTERRUPTED 252
240 HAND DEFORMITY 250
241 VERTIGO 249
242 HAEMORRHAGE 247
243 TREATMENT NONCOMPLIANCE 246
244 SINUS DISORDER 245
245 SEPTIC SHOCK 244
246 DYSURIA 243
247 PEMPHIGUS 243
248 LIMB INJURY 242
249 APHASIA 241
250 GASTROINTESTINAL HAEMORRHAGE 240
251 SPEECH DISORDER 238
252 HEPATIC STEATOSIS 237
253 UNDERDOSE 237
254 CHOLELITHIASIS 236
255 HYPOXIA 236
256 DYSPHONIA 234
257 MEDICATION ERROR 234
258 HYPOMAGNESAEMIA 233
259 ACUTE MYOCARDIAL INFARCTION 229
260 INTERSTITIAL LUNG DISEASE 229
261 ANGINA PECTORIS 228
262 BLOOD GLUCOSE ABNORMAL 228
263 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 224
264 HAEMODIALYSIS 224
265 CYSTITIS 222
266 HEPATITIS 222
267 SEASONAL ALLERGY 222
268 HERPES ZOSTER 218
269 AMNESIA 217
270 ASPARTATE AMINOTRANSFERASE INCREASED 217
271 HALLUCINATION 216
272 CARDIO-RESPIRATORY ARREST 215
273 PANCYTOPENIA 215
274 BACK INJURY 214
275 HAEMATURIA 214
276 HYPOTHERMIA 214
277 PRODUCT DOSE OMISSION IN ERROR 214
278 PULMONARY FIBROSIS 214
279 OBSTRUCTIVE AIRWAYS DISORDER 212
280 DISEASE PROGRESSION 210
281 BLEPHAROSPASM 208
282 FACET JOINT SYNDROME 208
283 SURGERY 208
284 INJECTION SITE ERYTHEMA 207
285 ACCIDENTAL OVERDOSE 206
286 HYPOGLYCAEMIC COMA 206
287 LIVER DISORDER 206
288 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 204
289 INJECTION SITE REACTION 203
290 PERIPHERAL VENOUS DISEASE 203
291 AGITATION 202
292 NO ADVERSE EVENT 202
293 PLEURAL EFFUSION 202
294 PRODUCT SUBSTITUTION ISSUE 202
295 RENAL DISORDER 201
296 KETOACIDOSIS 200
297 THERAPEUTIC RESPONSE DECREASED 200
298 EATING DISORDER 199
299 THERAPY NON-RESPONDER 199
300 WHITE BLOOD CELL COUNT INCREASED 199
301 DUODENAL ULCER PERFORATION 198
302 MALIGNANT NEOPLASM PROGRESSION 198
303 PULMONARY OEDEMA 198
304 DRUG DOSE OMISSION 197
305 MUSCLE INJURY 197
306 OSTEOPOROSIS 197
307 BREAST CANCER STAGE III 196
308 HELICOBACTER INFECTION 196
309 HYPERCHOLESTEROLAEMIA 196
310 HYPOPHAGIA 196
311 NAIL DISORDER 196
312 ECZEMA 195
313 ANURIA 194
314 C-REACTIVE PROTEIN ABNORMAL 194
315 HEMIPARESIS 194
316 LIVER FUNCTION TEST INCREASED 193
317 THROAT IRRITATION 193
318 TUBULOINTERSTITIAL NEPHRITIS 192
319 HAEMOPTYSIS 191
320 DRY EYE 190
321 ONYCHOMYCOSIS 189
322 WOUND INFECTION 189
323 FEELING COLD 187
324 ENCEPHALOPATHY 186
325 ONYCHOMADESIS 186
326 ARRHYTHMIA 185
327 BLOOD GLUCOSE FLUCTUATION 184
328 RASH PRURITIC 184
329 SUICIDAL IDEATION 184
330 INFUSION SITE PAIN 183
331 SKIN HAEMORRHAGE 183
332 URINARY INCONTINENCE 182
333 PRODUCT ODOUR ABNORMAL 181
334 CORONARY ARTERY DISEASE 180
335 DISTURBANCE IN ATTENTION 180
336 EYE IRRITATION 180
337 DELIRIUM 179
338 LIP DRY 179
339 DRUG ABUSE 178
340 DEPRESSED LEVEL OF CONSCIOUSNESS 177
341 HYPERLACTACIDAEMIA 177
342 FULL BLOOD COUNT ABNORMAL 176
343 HEAD INJURY 174
344 HEPATIC CIRRHOSIS 173
345 TRANSIENT ISCHAEMIC ATTACK 172
346 DERMATITIS ATOPIC 170
347 OCULAR HYPERAEMIA 169
348 RECTAL HAEMORRHAGE 169
349 FEBRILE NEUTROPENIA 167
350 VITAMIN B12 DEFICIENCY 167
351 LIVE BIRTH 166
352 DIVERTICULITIS 165
353 HAEMATOCHEZIA 165
354 ALTERED STATE OF CONSCIOUSNESS 164
355 BLOOD POTASSIUM DECREASED 164
356 DEEP VEIN THROMBOSIS 164
357 HYPOCALCAEMIA 163
358 HEMIPLEGIA 162
359 JOINT INJURY 161
360 ANGIOEDEMA 160
361 HEART RATE DECREASED 160
362 SKIN DISCOLOURATION 160
363 SWELLING FACE 160
364 RED BLOOD CELL COUNT DECREASED 158
365 HEPATIC FUNCTION ABNORMAL 157
366 MOVEMENT DISORDER 157
367 RESPIRATORY TRACT CONGESTION 157
368 SLEEP APNOEA SYNDROME 157
369 HEPATIC CYTOLYSIS 155
370 HYPOACUSIS 155
371 NEOPLASM MALIGNANT 155
372 NERVOUSNESS 154
373 RESPIRATORY DISORDER 154
374 COGNITIVE DISORDER 153
375 INJECTION SITE BRUISING 153
376 LOCALISED INFECTION 153
377 LIMB DISCOMFORT 152
378 BONE PAIN 151
379 INJECTION SITE SWELLING 151
380 AFFECT LABILITY 150
381 BLOOD CREATINE PHOSPHOKINASE INCREASED 150
382 PREMATURE BABY 150
383 EYE SWELLING 149
384 BLINDNESS 148
385 EAR INFECTION 148
386 DISORIENTATION 146
387 NEUTROPHIL COUNT DECREASED 146
388 RASH ERYTHEMATOUS 145
389 EAR PAIN 143
390 EMOTIONAL DISTRESS 143
391 LACRIMATION INCREASED 143
392 PANIC ATTACK 143
393 UNEVALUABLE EVENT 143
394 URINARY RETENTION 143
395 COORDINATION ABNORMAL 142
396 PRESYNCOPE 142
397 UNRESPONSIVE TO STIMULI 142
398 BLOOD LACTIC ACID INCREASED 141
399 CEREBRAL INFARCTION 141
400 ELECTROCARDIOGRAM QT PROLONGED 141
401 FUNGAL INFECTION 141
402 ACIDOSIS 140
403 GRIP STRENGTH DECREASED 140
404 INTENTIONAL DOSE OMISSION 140
405 RALES 140
406 RHEUMATIC FEVER 140
407 BLOOD IRON DECREASED 139
408 CEREBRAL HAEMORRHAGE 139
409 HYPERSOMNIA 139
410 MENTAL STATUS CHANGES 139
411 SKIN ULCER 139
412 MELAENA 138
413 INJECTION SITE HAEMORRHAGE 137
414 PNEUMONIA ASPIRATION 137
415 SENSORY LOSS 136
416 VASCULITIS 136
417 HYPOKINESIA 135
418 MOTOR DYSFUNCTION 135
419 MUSCLE SPASTICITY 135
420 RESTLESSNESS 135
421 SKIN FISSURES 134
422 ADVERSE REACTION 133
423 BLOOD URINE PRESENT 133
424 EYE DISORDER 133
425 ROAD TRAFFIC ACCIDENT 133
426 SCIATICA 133
427 ARTERIOSCLEROSIS CORONARY ARTERY 132
428 GLOMERULAR FILTRATION RATE DECREASED 132
429 SNEEZING 132
430 MENTAL DISORDER 131
431 TACHYPNOEA 131
432 ACCIDENTAL EXPOSURE TO PRODUCT 130
433 EYE PRURITUS 130
434 GAMMA-GLUTAMYLTRANSFERASE INCREASED 130
435 GLAUCOMA 130
436 INJECTION SITE PRURITUS 130
437 AGEUSIA 129
438 DYSSTASIA 129
439 GASTROENTERITIS 129
440 PEMPHIGOID 129
441 RESPIRATORY TRACT INFECTION 129
442 PERSONALITY DISORDER 128
443 COLITIS 127
444 CONGENITAL ANOMALY 126
445 FINGER DEFORMITY 126
446 PRODUCT ADMINISTRATION INTERRUPTED 126
447 RESPIRATORY DISTRESS 126
448 FREQUENT BOWEL MOVEMENTS 125
449 GASTRIC DISORDER 125
450 NEURALGIA 125
451 NEUROLOGICAL SYMPTOM 125
452 SKIN DISORDER 125
453 SOPOR 125
454 VIRAL INFECTION 125
455 BLOOD POTASSIUM INCREASED 124
456 INSURANCE ISSUE 124
457 INTERNATIONAL NORMALISED RATIO INCREASED 123
458 LEUKOCYTOSIS 123
459 CARDIOGENIC SHOCK 122
460 HAEMATOCRIT DECREASED 122
461 ADJUSTMENT DISORDER 120
462 CAROTID ARTERY THROMBOSIS 120
463 GASTRITIS 120
464 PULMONARY ALVEOLAR HAEMORRHAGE 120
465 BLOOD TRIGLYCERIDES INCREASED 119
466 ELECTROLYTE IMBALANCE 119
467 HEPATIC FAILURE 119
468 ISCHAEMIC STROKE 119
469 BLOOD PRESSURE ABNORMAL 117
470 BLOOD PRESSURE FLUCTUATION 117
471 SKIN BURNING SENSATION 117
472 ERECTILE DYSFUNCTION 116
473 PULMONARY VASCULITIS 116
474 RENAL INJURY 116
475 HAEMATEMESIS 115
476 IMPAIRED GASTRIC EMPTYING 115
477 EOSINOPHILIA 114
478 MULTIPLE SCLEROSIS RELAPSE 114
479 NEUROLOGIC NEGLECT SYNDROME 114
480 RENAL TUBULAR NECROSIS 114
481 SKIN LESION 114
482 ACUTE RESPIRATORY FAILURE 113
483 CARDIOVASCULAR DISORDER 113
484 CIRCULATORY COLLAPSE 113
485 HYPOVOLAEMIA 113
486 RESPIRATORY SYMPTOM 113
487 BLADDER CANCER 112
488 BODY TEMPERATURE DECREASED 112
489 COELIAC DISEASE 112
490 SINUS TACHYCARDIA 112
491 ARTERIOSCLEROSIS 111
492 DEVICE ISSUE 111
493 SINUS CONGESTION 110
494 TINNITUS 110
495 THIRST 109
496 BLOOD SODIUM DECREASED 108
497 BLOOD UREA INCREASED 108
498 INFUSION SITE ERYTHEMA 108
499 PRODUCT PRESCRIBING ERROR 108
500 RETCHING 108
501 BREAST CANCER 107
502 IRRITABILITY 107
503 LEUKOPENIA 107
504 PULMONARY HYPERTENSION 107
505 CHOLESTASIS 106
506 DYSKINESIA 106
507 HAEMATOMA 106
508 HAEMODYNAMIC INSTABILITY 106
509 INJECTION SITE MASS 106
510 LYMPHADENOPATHY 106
511 POLYURIA 106
512 CHOKING 105
513 PREMATURE DELIVERY 105
514 PRESCRIBED OVERDOSE 105
515 SWOLLEN TONGUE 105
516 BODY TEMPERATURE INCREASED 104
517 DIABETIC NEUROPATHY 104
518 DIPLOPIA 104
519 NEEDLE ISSUE 104
520 NOCTURIA 104
521 BASAL CELL CARCINOMA 103
522 DIABETIC METABOLIC DECOMPENSATION 103
523 FOOT FRACTURE 103
524 NEURITIS 103
525 THERAPEUTIC RESPONSE SHORTENED 103
526 GANGRENE 102
527 PRODUCT STORAGE ERROR 102
528 CHOLECYSTITIS 101
529 HALLUCINATION, VISUAL 101
530 HERNIA 101
531 INTESTINAL OBSTRUCTION 101
532 PROSTATE CANCER 101
533 RASH MACULAR 101
534 THERAPEUTIC RESPONSE UNEXPECTED 101
535 HYPOAESTHESIA ORAL 100
536 MIDDLE INSOMNIA 100
537 EJECTION FRACTION DECREASED 99
538 MEDICATION RESIDUE PRESENT 99
539 RESTLESS LEGS SYNDROME 99
540 FAECES DISCOLOURED 98
541 PAIN IN JAW 98
542 PRODUCT ADMINISTRATION ERROR 98
543 RED BLOOD CELL SEDIMENTATION RATE INCREASED 98
544 ANKLE FRACTURE 97
545 BRONCHIECTASIS 97
546 DEMENTIA 97
547 DISTRIBUTIVE SHOCK 97
548 GASTRIC ULCER 97
549 GOUT 97
550 HYPERTHYROIDISM 97
551 MITRAL VALVE INCOMPETENCE 97
552 VISUAL ACUITY REDUCED 97
553 ASCITES 96
554 ORTHOSTATIC HYPOTENSION 96
555 PROCEDURAL PAIN 96
556 COVID-19 PNEUMONIA 95
557 DRUG DEPENDENCE 95
558 GASTROENTERITIS VIRAL 95
559 RESPIRATORY ARREST 95
560 SKIN LACERATION 95
561 FEEDING DISORDER 94
562 JAUNDICE 94
563 BLOOD ALKALINE PHOSPHATASE INCREASED 93
564 MUSCULOSKELETAL CHEST PAIN 93
565 MYOPATHY 93
566 ACUTE RESPIRATORY DISTRESS SYNDROME 92
567 CARDIOMYOPATHY 92
568 FLANK PAIN 92
569 INTERVERTEBRAL DISC PROTRUSION 92
570 PHOTOPHOBIA 92
571 PRODUCT TASTE ABNORMAL 92
572 PULMONARY MASS 92
573 MOUTH HAEMORRHAGE 91
574 LYMPHOCYTE COUNT DECREASED 90
575 MULTIPLE SCLEROSIS 90
576 PANCREATIC CARCINOMA 90
577 RASH MACULO-PAPULAR 90
578 COLD SWEAT 89
579 EXOSTOSIS 89
580 POOR QUALITY SLEEP 89
581 PRESCRIBED UNDERDOSE 89
582 TOXIC ENCEPHALOPATHY 89
583 ABDOMINAL PAIN LOWER 88
584 AGRANULOCYTOSIS 88
585 BLOOD PRESSURE DIASTOLIC DECREASED 88
586 PRODUCT RESIDUE PRESENT 88
587 TRANSAMINASES INCREASED 88
588 BRAIN FOG 87
589 CROHN^S DISEASE 87
590 DERMATITIS CONTACT 87
591 DEVICE MALFUNCTION 87
592 LIVER FUNCTION TEST ABNORMAL 87
593 MULTIPLE ALLERGIES 87
594 NORMAL NEWBORN 87
595 PALLOR 87
596 PSYCHOTIC DISORDER 87
597 UROSEPSIS 87
598 ABORTION SPONTANEOUS 86
599 ARTERIAL OCCLUSIVE DISEASE 86
600 IMPAIRED WORK ABILITY 86
601 MICTURITION URGENCY 86
602 PRODUCT LABEL CONFUSION 86
603 AGGRESSION 85
604 CYTOKINE RELEASE SYNDROME 85
605 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 85
606 HEART RATE IRREGULAR 85
607 HIP FRACTURE 85
608 MYOCARDITIS 85
609 PRODUCT DISPENSING ERROR 85
610 PYELONEPHRITIS 85
611 RIB FRACTURE 85
612 JOINT STIFFNESS 84
613 RENAL CYST 84
614 CANDIDA INFECTION 83
615 HYPERCALCAEMIA 83
616 HYPERLIPIDAEMIA 83
617 INFUSION SITE SWELLING 83
618 NODULE 83
619 PERICARDIAL EFFUSION 83
620 WOUND COMPLICATION 83
621 HAEMORRHOIDS 82
622 LABORATORY TEST ABNORMAL 82
623 DIALYSIS 81
624 KIDNEY INFECTION 81
625 METASTASES TO LIVER 81
626 APPETITE DISORDER 80
627 BACTERIAL INFECTION 80
628 CAESAREAN SECTION 80
629 DRUG LEVEL ABOVE THERAPEUTIC 80
630 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 80
631 INFUSION SITE HAEMORRHAGE 80
632 LOWER LIMB FRACTURE 79
633 MYOCARDIAL ISCHAEMIA 79
634 PROTEINURIA 79
635 VENTRICULAR TACHYCARDIA 79
636 ABNORMAL BEHAVIOUR 78
637 ANAL INCONTINENCE 78
638 ANGER 78
639 ERUCTATION 78
640 MENTAL IMPAIRMENT 78
641 PARKINSONISM 78
642 STAPHYLOCOCCAL INFECTION 78
643 BLINDNESS TRANSIENT 77
644 BLOOD LACTATE DEHYDROGENASE INCREASED 77
645 CARPAL TUNNEL SYNDROME 77
646 FULL BLOOD COUNT DECREASED 77
647 PULMONARY CONGESTION 77
648 THERAPY CESSATION 77
649 BLOOD MAGNESIUM DECREASED 76
650 HAEMOLYTIC ANAEMIA 76
651 NERVOUS SYSTEM DISORDER 76
652 RESPIRATION ABNORMAL 76
653 EXPOSURE VIA INGESTION 75
654 INCORRECT PRODUCT ADMINISTRATION DURATION 75
655 KNEE ARTHROPLASTY 75
656 MYOSITIS 75
657 OCULAR DISCOMFORT 75
658 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 74
659 PRODUCT AVAILABILITY ISSUE 74
660 ACUTE CORONARY SYNDROME 73
661 BLOOD BILIRUBIN INCREASED 73
662 DISEASE RECURRENCE 73
663 DRUG ERUPTION 73
664 FOOT DEFORMITY 73
665 FOURNIER^S GANGRENE 73
666 NORMOCHROMIC NORMOCYTIC ANAEMIA 73
667 POLYMYALGIA RHEUMATICA 73
668 ACNE 72
669 COLITIS ULCERATIVE 72
670 DRUG EFFECT LESS THAN EXPECTED 72
671 HALLUCINATION, AUDITORY 72
672 HEPATOTOXICITY 72
673 HYPOVOLAEMIC SHOCK 72
674 MOOD ALTERED 72
675 MUCOSAL INFLAMMATION 72
676 ORAL PAIN 72
677 THROAT TIGHTNESS 72
678 CONJUNCTIVITIS ALLERGIC 71
679 CRYING 71
680 DIZZINESS POSTURAL 71
681 END STAGE RENAL DISEASE 71
682 EXPOSURE VIA SKIN CONTACT 71
683 LUNG NEOPLASM MALIGNANT 71
684 MUSCULOSKELETAL DISCOMFORT 71
685 PULSELESS ELECTRICAL ACTIVITY 71
686 RESPIRATORY RATE INCREASED 71
687 TROPONIN INCREASED 71
688 DISABILITY 70
689 INCREASED APPETITE 70
690 MULTI-ORGAN FAILURE 70
691 NEPHROPATHY 70
692 NIGHTMARE 70
693 SPUTUM DISCOLOURED 70
694 BACK DISORDER 69
695 DELUSION 69
696 FEMUR FRACTURE 69
697 PARANASAL SINUS DISCOMFORT 69
698 PRODUCT DOSE OMISSION 69
699 PRODUCT USE COMPLAINT 69
700 ANAPHYLACTIC SHOCK 68
701 DIABETIC RETINOPATHY 68
702 FORCED EXPIRATORY VOLUME DECREASED 68
703 OLIGURIA 68
704 TOOTHACHE 68
705 SKIN REACTION 67
706 SMALL INTESTINAL OBSTRUCTION 67
707 SPIROMETRY ABNORMAL 67
708 TENDONITIS 67
709 TOOTH INFECTION 67
710 VITAMIN D DEFICIENCY 67
711 WEIGHT FLUCTUATION 67
712 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 66
713 NASAL POLYPS 66
714 PNEUMONITIS 66
715 CHROMATURIA 65
716 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 65
717 HAEMOGLOBIN INCREASED 65
718 HYPERTENSIVE CRISIS 65
719 OSTEOMYELITIS 65
720 TOXIC EPIDERMAL NECROLYSIS 65
721 URINE OUTPUT DECREASED 65
722 CORONARY ARTERY OCCLUSION 64
723 INFUSION SITE DISCHARGE 64
724 ORAL HERPES 64
725 GALLBLADDER DISORDER 63
726 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 63
727 INFUSION SITE REACTION 63
728 NEOPLASM 63
729 PHOTOSENSITIVITY REACTION 63
730 DEAFNESS 62
731 EXTRA DOSE ADMINISTERED 62
732 SECRETION DISCHARGE 62
733 SINUS PAIN 62
734 VENTRICULAR FIBRILLATION 62
735 CARDIOMEGALY 61
736 CONTINUOUS HAEMODIAFILTRATION 61
737 EXPIRED PRODUCT ADMINISTERED 61
738 HUNGER 61
739 POISONING 61
740 PRODUCT DISTRIBUTION ISSUE 61
741 UPPER GASTROINTESTINAL HAEMORRHAGE 61
742 ACUTE HEPATIC FAILURE 60
743 DISLOCATION OF VERTEBRA 60
744 EAR CONGESTION 60
745 FRUSTRATION TOLERANCE DECREASED 60
746 GASTROINTESTINAL INFECTION 60
747 GLUCOSE TOLERANCE IMPAIRED 60
748 INTENTIONAL SELF-INJURY 60
749 VITAMIN B12 DECREASED 60
750 ADRENAL INSUFFICIENCY 59
751 ASPIRATION 59
752 ATRIOVENTRICULAR BLOCK COMPLETE 59
753 BLADDER PAIN 59
754 BONE EROSION 59
755 EYE HAEMORRHAGE 59
756 LIP SWELLING 59
757 PRURITUS GENERALISED 59
758 TOXIC SKIN ERUPTION 59
759 WOUND SECRETION 59
760 COAGULOPATHY 58
761 HEAD DISCOMFORT 58
762 MYCOTIC ALLERGY 58
763 NEOPLASM PROGRESSION 58
764 PHARYNGITIS 58
765 POTENTIATING DRUG INTERACTION 58
766 SHOCK HAEMORRHAGIC 58
767 TOOTH DISORDER 58
768 ANIMAL SCRATCH 57
769 DUST ALLERGY 57
770 EXTRAPYRAMIDAL DISORDER 57
771 HIATUS HERNIA 57
772 LARYNGITIS 57
773 LEFT VENTRICULAR DYSFUNCTION 57
774 LIPASE INCREASED 57
775 METASTASES TO BONE 57
776 MUSCLE ATROPHY 57
777 SARS-COV-2 TEST POSITIVE 57
778 TOTAL LUNG CAPACITY ABNORMAL 57
779 COLON CANCER 56
780 DERMATITIS 56
781 DIABETIC NEPHROPATHY 56
782 HYPERVOLAEMIA 56
783 INITIAL INSOMNIA 56
784 MITE ALLERGY 56
785 PNEUMOTHORAX 56
786 SCHIZOPHRENIA 56
787 URINARY TRACT DISCOMFORT 56
788 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 56
789 BRAIN INJURY 55
790 CEREBRAL HYPOPERFUSION 55
791 CONVULSION 55
792 DEVICE DISLOCATION 55
793 DISSEMINATED INTRAVASCULAR COAGULATION 55
794 IRON DEFICIENCY ANAEMIA 55
795 MUSCLE RIGIDITY 55
796 PARKINSON^S DISEASE 55
797 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 55
798 ROTATOR CUFF SYNDROME 55
799 ULCER 55
800 WRIST FRACTURE 55
801 ALVEOLAR OSTEITIS 54
802 ATRIOVENTRICULAR BLOCK 54
803 DEVICE LEAKAGE 54
804 DYSLIPIDAEMIA 54
805 FOREIGN BODY SENSATION IN EYES 54
806 HUMAN RHINOVIRUS TEST POSITIVE 54
807 HYPERNATRAEMIA 54
808 INTERNAL HAEMORRHAGE 54
809 KETOSIS 54
810 LARGE INTESTINE POLYP 54
811 PERIPHERAL COLDNESS 54
812 POLYNEUROPATHY 54
813 SCRATCH 54
814 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 53
815 CARDIAC MURMUR 53
816 FEAR 53
817 ORAL CANDIDIASIS 53
818 TUNNEL VISION 53
819 ANOSMIA 52
820 AUTOIMMUNE DISORDER 52
821 GINGIVAL BLEEDING 52
822 HYPOCHOLESTEROLAEMIA 52
823 INFLAMMATORY MARKER INCREASED 52
824 LOW BIRTH WEIGHT BABY 52
825 PAIN OF SKIN 52
826 PRE-EXISTING CONDITION IMPROVED 52
827 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 52
828 SCAB 52
829 THERAPY PARTIAL RESPONDER 52
830 BLOOD COUNT ABNORMAL 51
831 HEPATIC FIBROSIS 51
832 HYPOPHOSPHATAEMIA 51
833 METABOLIC DISORDER 51
834 OVERWEIGHT 51
835 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 51
836 PRODUCT PRESCRIBING ISSUE 51
837 SKIN INFECTION 51
838 BLOOD TEST ABNORMAL 50
839 GENERALISED OEDEMA 50
840 GENERALISED TONIC-CLONIC SEIZURE 50
841 IMMUNODEFICIENCY 50
842 METASTASES TO LUNG 50
843 MOOD SWINGS 50
844 PHARYNGEAL SWELLING 50
845 PULMONARY ARTERIAL HYPERTENSION 50
846 SINUS BRADYCARDIA 50
847 SPINAL OPERATION 50
848 TENDERNESS 50
849 THYROID DISORDER 50
850 VAGINAL HAEMORRHAGE 50
851 ABNORMAL DREAMS 49
852 HIP ARTHROPLASTY 49
853 INJECTION SITE NODULE 49
854 NEUROLEPTIC MALIGNANT SYNDROME 49
855 POISONING DELIBERATE 49
856 RASH GENERALISED 49
857 SPINAL OSTEOARTHRITIS 49
858 THYROID CANCER 49
859 TRICUSPID VALVE INCOMPETENCE 49
860 BENIGN PROSTATIC HYPERPLASIA 48
861 BLOOD THYROID STIMULATING HORMONE INCREASED 48
862 CUTANEOUS VASCULITIS 48
863 DECREASED ACTIVITY 48
864 DECUBITUS ULCER 48
865 KERATITIS 48
866 OESOPHAGITIS 48
867 PREGNANCY 48
868 PRODUCT SOLUBILITY ABNORMAL 48
869 RED CELL DISTRIBUTION WIDTH INCREASED 48
870 SKIN INJURY 48
871 WITHDRAWAL SYNDROME 48
872 ANHEDONIA 47
873 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 47
874 BODY HEIGHT DECREASED 47
875 DEPRESSIVE SYMPTOM 47
876 LIGAMENT SPRAIN 47
877 MALNUTRITION 47
878 MUSCLE TIGHTNESS 47
879 OROPHARYNGEAL DISCOMFORT 47
880 PANCREATIC CARCINOMA METASTATIC 47
881 POLYDIPSIA 47
882 POST PROCEDURAL COMPLICATION 47
883 SCAR 47
884 SKIN CANCER 47
885 SUDDEN DEATH 47
886 VASOPLEGIA SYNDROME 47
887 BLOOD PRESSURE INADEQUATELY CONTROLLED 46
888 BLOOD PRESSURE SYSTOLIC DECREASED 46
889 BRADYKINESIA 46
890 CHOKING SENSATION 46
891 CORONARY ARTERY STENOSIS 46
892 EYELID PAIN 46
893 HYPERTRIGLYCERIDAEMIA 46
894 INFUSION SITE INFECTION 46
895 INFUSION SITE PRURITUS 46
896 INJECTION SITE RASH 46
897 NERVE INJURY 46
898 OPTIC ISCHAEMIC NEUROPATHY 46
899 PRODUCT PHYSICAL ISSUE 46
900 SUBDURAL HAEMATOMA 46
901 TONGUE BITING 46
902 AZOTAEMIA 45
903 CHOLECYSTECTOMY 45
904 DRUG ADMINISTRATION ERROR 45
905 FAECES SOFT 45
906 MUSCULOSKELETAL DISORDER 45
907 SKIN IRRITATION 45
908 ALANINE AMINOTRANSFERASE ABNORMAL 44
909 BONE DISORDER 44
910 CYANOSIS 44
911 DEEP VEIN THROMBOSIS POSTOPERATIVE 44
912 EMOTIONAL DISORDER 44
913 EUPHORIC MOOD 44
914 GASTRIC HAEMORRHAGE 44
915 IMPAIRED QUALITY OF LIFE 44
916 INCONTINENCE 44
917 PERIPHERAL VASCULAR DISORDER 44
918 PLASMA CELL MYELOMA 44
919 PROSTATIC SPECIFIC ANTIGEN INCREASED 44
920 UPPER LIMB FRACTURE 44
921 VENTRICULAR EXTRASYSTOLES 44
922 BLOOD URIC ACID INCREASED 43
923 BREATH SOUNDS ABNORMAL 43
924 CONCOMITANT DISEASE AGGRAVATED 43
925 DUODENAL ULCER 43
926 ILEUS 43
927 NEPHROGENIC ANAEMIA 43
928 OSTEONECROSIS 43
929 PNEUMONIA HAEMOPHILUS 43
930 URINE KETONE BODY PRESENT 43
931 WALKING AID USER 43
932 WRONG PATIENT RECEIVED PRODUCT 43
933 ABNORMAL LOSS OF WEIGHT 42
934 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 42
935 BLOOD CHOLESTEROL ABNORMAL 42
936 CATARACT OPERATION 42
937 COMA SCALE ABNORMAL 42
938 HEPATITIS ACUTE 42
939 KNEE OPERATION 42
940 PLATELET COUNT INCREASED 42
941 SPINAL PAIN 42
942 TOOTH ABSCESS 42
943 ATRIAL SEPTAL DEFECT 41
944 CAPILLARITIS 41
945 CARDIAC DYSFUNCTION 41
946 CONJUNCTIVITIS 41
947 ERYTHEMA MULTIFORME 41
948 EYE INFECTION 41
949 HEREDITARY ANGIOEDEMA 41
950 HYPOGLYCAEMIA NEONATAL 41
951 INFUSION SITE BRUISING 41
952 LEFT VENTRICULAR HYPERTROPHY 41
953 MYELOSUPPRESSION 41
954 ORAL DISCOMFORT 41
955 OSTEOLYSIS 41
956 PARAESTHESIA ORAL 41
957 PAROSMIA 41
958 RENAL PAIN 41
959 UPPER-AIRWAY COUGH SYNDROME 41
960 CHOLECYSTITIS ACUTE 40
961 DIARRHOEA HAEMORRHAGIC 40
962 FACE OEDEMA 40
963 HEART SOUNDS 40
964 IRON DEFICIENCY 40
965 LYMPHOPENIA 40
966 PROLONGED EXPIRATION 40
967 PURPURA 40
968 RENAL CANCER 40
969 VITREOUS FLOATERS 40
970 WRONG PRODUCT ADMINISTERED 40
971 ABSCESS 39
972 ANGINA UNSTABLE 39
973 ATRIOVENTRICULAR BLOCK FIRST DEGREE 39
974 BACTERAEMIA 39
975 BLOOD SODIUM INCREASED 39
976 BOWEL MOVEMENT IRREGULARITY 39
977 DEVICE USE ISSUE 39
978 DRUG EFFECT DECREASED 39
979 ECONOMIC PROBLEM 39
980 ESCHERICHIA URINARY TRACT INFECTION 39
981 GASTROINTESTINAL PAIN 39
982 HEPATOMEGALY 39
983 HYPERVENTILATION 39
984 INJECTION SITE DISCOLOURATION 39
985 MANIA 39
986 PARALYSIS 39
987 PARANOIA 39
988 SENSORY DISTURBANCE 39
989 SPINAL FRACTURE 39
990 VIRAL TEST POSITIVE 39
991 APHONIA 38
992 BRADYPHRENIA 38
993 CHOLANGITIS 38
994 CYST 38
995 FAECALOMA 38
996 FEELING JITTERY 38
997 GINGIVAL PAIN 38
998 HYPERURICAEMIA 38
999 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 38